CLNN 株価分析 — Clene Inc. (Consumer Defensive >> Packaged Foods)
CLNN に関するよくある質問
CLNNのROE(自己資本利益率)は?
Clene Inc.のROEは178.20%です。
CLNNの配当利回りは?
Clene Inc.の配当利回りは0.00%です。
CLNNの品質スコア(Quality Score)は?
当社のAIはCLNNの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
CLNNは今が買い時ですか?
当社AIのタイミングスコアは100点中27点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
CLNNはどのセクターに属しますか?
Clene Inc.はConsumer Defensive >> Packaged Foodsセクターに分類されます(NASDAQ市場)
CLNN AI Analysis Summary
Our AI summary for CLNN: Clene Inc. (NASDAQ), Consumer Defensive >> Packaged Foods sector. The stock currently trades at a P/E of 0.00, ROE of 178.20%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 5.02
Price
-0.03
(-0.50%)
Day Change
|
|
|---|
CLNN, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.02 |
| PBV / Sector |
-3.42 / 1.75
|
| Earning Per Share | -2.61 |
| PE / Sector |
N/A / 19.08
|
| PEG or PE/Growth / Sector |
N/A / -1.45
|
| Average 1M Daily Value |
0.35 M
GREAT
|
| Average 1W Daily Value |
0.33 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
39% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:39 |
| Symbol | CLNN |
| Name | CLENE INC. |
| Sector | Consumer Defensive >> Packaged Foods |
| Market | NASDAQ |
| Listed Shares | 12.78 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 64.40 / 5,029.34 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 6550 South Millrock Drive, Salt Lake City, UT, United States, 84121
Phone: 801 676 9695
Website: https://clene.com
Employees: 76
Description: Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. It develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, the company markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. Clene Inc. is headquartered in Salt Lake City, Utah.
Analyst Ratings & Target Price
ME vs SECTOR Consumer Defensive >> Packaged Foods
Click a bubble to view stock details · Bubble size represents market capitalization share
Google